The P2Y12 receptor is a G-protein-coupled receptor (GPCR) critical in platelet activation and thrombosis. It binds adenosine diphosphate (ATP) and is a key therapeutic target for antiplatelet therapies .
Key Characteristics of P2RY12:
| Property | Description |
|---|---|
| Gene Symbol | P2RY12 |
| Protein Function | Mediates platelet aggregation and thrombus stabilization |
| Tissue Expression | Platelets, microglia, eosinophils |
| Therapeutic Relevance | Target for drugs like clopidogrel and ticagrelor |
The Anti-P2Y12 Receptor Antibody (#APR-012) is a well-characterized reagent for studying P2RY12 biology .
Flow Cytometry: Detects P2RY12 expression in human eosinophils .
Immunocytochemistry: Localizes P2RY12 in cellular compartments (e.g., membrane/cytoplasm) .
Key Findings from Muniz et al. (2015):
Demonstrated P2RY12 expression in eosinophils using APR-012 .
Preabsorption with blocking peptide abolished signal, confirming specificity .
Figure 1. Anti-P2Y12 Antibody Validation (Adapted from ):
.
While APR-012 itself is a research tool, P2RY12 inhibitors (e.g., clopidogrel) are widely used to prevent cardiovascular events. Studies suggest broader roles for P2RY12 in neuroinflammation and immune responses, highlighting its multidisciplinary relevance .
PCR12 is a protein found in Arabidopsis thaliana, a model organism widely used in plant molecular biology. The PCR12 gene (AT1G68630) encodes a protein that plays roles in plant cellular processes. Researchers study PCR12 to understand plant development, stress responses, and cellular signaling pathways. The PCR12 antibody enables detection and quantification of this protein in various experimental contexts. Antibodies against plant proteins like PCR12 are essential tools for advancing our understanding of plant biology at the molecular level .
The PCR12 antibody (CSB-PA890464XA01DOA-2) has been validated for ELISA (Enzyme-Linked Immunosorbent Assay) and WB (Western Blot) applications in plant samples. These techniques allow researchers to detect and quantify PCR12 protein in complex biological samples. The antibody is an affinity-purified rabbit polyclonal antibody raised against recombinant Arabidopsis thaliana PCR12 protein. Each antibody preparation typically includes 2mg of purified antibody along with positive control antigens (200μg) and pre-immune serum as a negative control .
Polyclonal PCR12 antibodies, like CSB-PA890464XA01DOA-2, contain a mixture of antibodies that recognize multiple epitopes on the PCR12 protein. This characteristic provides advantages in certain research contexts:
| Characteristic | Polyclonal PCR12 Antibody | Monoclonal Antibody |
|---|---|---|
| Epitope recognition | Multiple epitopes | Single epitope |
| Signal strength | Generally stronger signals | May have lower sensitivity |
| Tolerance to protein denaturation | More tolerant | Less tolerant |
| Batch-to-batch variation | Higher | Lower |
| Production method | Immunization of rabbits or other animals | Hybridoma technology |
| Cost | Generally lower | Generally higher |
Polyclonal antibodies like the PCR12 antibody are particularly useful for detecting low-abundance proteins and for applications where protein may be partially denatured (such as Western blotting) .
For optimal performance and longevity of the PCR12 antibody:
Store the antibody at -20°C or -80°C as recommended by the manufacturer
Avoid repeated freeze-thaw cycles by aliquoting the antibody before freezing
When handling, keep the antibody on ice
Centrifuge briefly before opening the vial to collect all material at the bottom
For dilutions, use high-quality buffers (typically PBS with 0.1% BSA or similar carrier protein)
For long-term storage solutions, consider adding preservatives like sodium azide (0.02%) to prevent microbial growth
Proper storage and handling are critical for maintaining antibody activity and ensuring reproducible experimental results .
While the optimal working dilution should be determined empirically for each application and experimental system, typical starting dilutions for polyclonal antibodies in Western blotting range from 1:200 to 1:1000. Based on the information available for similar antibodies:
Initial dilution recommendation: 1:400 for Western blotting
Blocking: 5% non-fat dry milk or 3-5% BSA in TBST (Tris-buffered saline with 0.1% Tween-20)
Primary antibody incubation: Overnight at 4°C or 1-2 hours at room temperature
Secondary antibody: Anti-rabbit IgG conjugated with HRP at 1:5000 dilution
Detection: Enhanced chemiluminescence (ECL) substrate
Always include proper controls, including the provided pre-immune serum as a negative control and the provided antigen as a positive control to validate specificity .
Validating antibody specificity is critical for ensuring reliable results. For PCR12 antibody:
Positive control: Use the provided antigen (200μg) as a positive control
Negative control: Include the pre-immune serum provided with the antibody as a negative control
Knockout/knockdown validation: If available, test the antibody on samples from PCR12 knockout or knockdown plants
Peptide competition assay: Pre-incubate the antibody with excess PCR12 recombinant protein or peptide before application to samples; specific signals should be reduced or eliminated
Molecular weight verification: Confirm that the detected band matches the predicted molecular weight of PCR12
Cross-reactivity assessment: Test the antibody on samples from different plant species to determine specificity within the plant kingdom
Thorough validation ensures that the observed signals truly represent PCR12 and not non-specific binding .
Multiple bands in Western blots using PCR12 antibody could result from several factors:
Post-translational modifications: PCR12 protein may undergo modifications like phosphorylation or glycosylation, resulting in altered migration patterns
Protein isoforms: Alternative splicing may generate different PCR12 isoforms
Proteolytic degradation: Sample preparation without proper protease inhibitors may lead to degradation products
Non-specific binding: The polyclonal nature of the antibody may result in some cross-reactivity with similar proteins
To address and interpret multiple bands:
Include appropriate positive controls using recombinant PCR12 protein
Perform peptide competition assays to identify specific PCR12 bands
Use freshly prepared samples with protease inhibitors to minimize degradation
Consider using higher antibody dilutions to reduce non-specific binding
Optimize blocking conditions to minimize background signals
Careful analysis of band patterns across different samples and controls will help distinguish specific PCR12 signals from artifacts .
Common challenges and solutions in PCR12 antibody experiments include:
| Challenge | Potential Causes | Solutions |
|---|---|---|
| Weak or no signal | Insufficient protein, degraded antibody, incorrect dilutions | Increase protein loading, verify antibody activity, optimize dilutions |
| High background | Insufficient blocking, excessive antibody, poor washing | Increase blocking time/concentration, dilute antibody further, extend wash steps |
| Non-specific bands | Cross-reactivity, sample degradation | Use peptide competition, add protease inhibitors, optimize antibody dilution |
| Variable results between experiments | Inconsistent transfer, variable sample preparation | Standardize protocols, include loading controls, use consistent exposure times |
| False positives | Non-specific binding | Include appropriate negative controls, perform validation experiments |
Maintaining consistent experimental conditions and including proper controls are essential for generating reliable and reproducible results .
For accurate quantification of PCR12 protein levels:
Western blot quantification:
Include a standard curve using recombinant PCR12 protein at known concentrations
Use appropriate loading controls (e.g., actin or tubulin) for normalization
Ensure signal detection is within the linear range of your imaging system
Use image analysis software for densitometry analysis
ELISA quantification:
Develop a standard curve using the provided antigen at different concentrations
Run samples in triplicate to account for technical variation
Include appropriate positive and negative controls
Use statistical analyses to determine significance of observed differences
General considerations:
Minimize sample handling to reduce protein degradation
Maintain consistent experimental conditions across all samples
Validate results with complementary approaches (e.g., mRNA quantification)
Consider biological replicates to account for natural variation
Co-immunoprecipitation (Co-IP) using PCR12 antibody can reveal protein interaction partners:
Sample preparation:
Extract proteins under non-denaturing conditions to preserve native interactions
Use mild detergents (e.g., 0.5% NP-40 or 1% Triton X-100) in the lysis buffer
Include protease and phosphatase inhibitors to prevent degradation
Immunoprecipitation procedure:
Pre-clear lysates with Protein A/G beads to reduce non-specific binding
Incubate lysates with PCR12 antibody (typically 2-5 μg per mg of protein)
Capture antibody-protein complexes with Protein A/G beads
Wash thoroughly to remove non-specifically bound proteins
Elute bound proteins and analyze by Western blot or mass spectrometry
Controls:
Negative control: Pre-immune serum or IgG from the same species
Input control: Analysis of total lysate before immunoprecipitation
Validation: Confirm interactions with reciprocal Co-IPs when possible
This approach can identify novel interaction partners of PCR12 protein, providing insights into its functional roles in plant cells .
While the PCR12 antibody (CSB-PA890464XA01DOA-2) is not specifically validated for immunohistochemistry in the available information, researchers might adapt it for this purpose with these considerations:
Tissue preparation:
Fixation method significantly impacts epitope preservation (test paraformaldehyde, glutaraldehyde, or combinations)
Consider antigen retrieval methods to expose epitopes that may be masked during fixation
Section thickness affects antibody penetration (typically 5-10 μm for paraffin sections)
Protocol optimization:
Test a range of antibody dilutions (starting with 1:50 to 1:200)
Extend incubation times (overnight at 4°C may improve signal)
Include blocking steps with normal serum from the secondary antibody species
Use detergents (0.1-0.3% Triton X-100) to improve antibody penetration
Controls and validation:
Include sections without primary antibody
Use pre-immune serum as a negative control
Consider peptide competition assays to confirm specificity
When possible, compare with known expression patterns from in situ hybridization
Proper sample preparation and protocol optimization are critical for successful immunohistochemistry with PCR12 antibody in plant tissues .
Integrating PCR12 antibody-based assays into multi-omics studies can provide comprehensive insights into plant stress responses:
Proteomics integration:
Use PCR12 antibody for immunoprecipitation followed by mass spectrometry to identify post-translational modifications and interaction partners under stress conditions
Compare PCR12 protein levels (via Western blot) with global proteome changes from mass spectrometry
Transcriptomics correlation:
Correlate PCR12 protein levels with PCR12 gene expression data from RNA-Seq
Identify discrepancies between transcriptomic and proteomic data that may indicate post-transcriptional regulation
Metabolomics connections:
Correlate PCR12 protein abundance with changes in specific metabolites to infer functional relationships
Use PCR12 knockout/knockdown plants to identify metabolic pathways affected by PCR12 function
Data integration strategies:
Develop temporal profiles of PCR12 expression at protein and mRNA levels during stress responses
Use network analysis to position PCR12 within stress response pathways
Apply machine learning approaches to predict stress conditions based on PCR12 expression patterns
This integrated approach can reveal the functional significance of PCR12 in plant stress responses and identify potential applications in crop improvement .
If PCR12 is suspected to interact with DNA or chromatin-associated proteins, ChIP assays using PCR12 antibody might be considered:
Experimental design considerations:
Cross-linking optimization: Test different formaldehyde concentrations (typically 1-3%) and incubation times
Sonication parameters: Optimize to achieve chromatin fragments of 200-500 bp
Antibody amount: Typically 3-5 μg per ChIP reaction (may require empirical determination)
Positive controls: Include antibodies against known DNA-binding proteins
Negative controls: Pre-immune serum and IgG controls are essential
Protocol adaptations:
For plant tissues, additional cell wall disruption steps may be necessary
Consider dual cross-linking with disuccinimidyl glutarate (DSG) and formaldehyde for proteins not directly binding DNA
Include plant-specific protease inhibitors in all buffers
Data analysis:
Design primers for PCR/qPCR validation targeting predicted binding regions
Consider whole genome approaches (ChIP-seq) to identify all potential binding sites
Use bioinformatics tools to identify DNA motifs enriched in immunoprecipitated regions
Validation strategies:
Confirm direct DNA binding with electrophoretic mobility shift assays (EMSA)
Validate functional significance through reporter gene assays
Correlate binding with gene expression changes
These approaches can determine if PCR12 has direct or indirect roles in transcriptional regulation during plant development or stress responses .
When comparing PCR12 antibody-based detection with other plant protein detection systems:
Sensitivity comparison:
PCR12 polyclonal antibodies typically offer good sensitivity due to recognition of multiple epitopes
Sensitivity often depends on protein abundance; highly abundant proteins generally show better detection limits
Amplification systems (such as biotin-streptavidin) can improve detection for low-abundance proteins
Specificity considerations:
Cross-reactivity with related plant proteins may occur with polyclonal antibodies
Specificity challenges are common across plant research antibodies due to evolutionary conservation
Validation across multiple plant species is important to establish specificity boundaries
Technical comparison table:
| Detection System | Typical Sensitivity | Specificity | Common Applications | Limitations |
|---|---|---|---|---|
| PCR12 Antibody | Nanogram range | Species-specific | WB, ELISA | May cross-react with homologs |
| Anti-plant hormone antibodies | Picogram range | Variable | ELISA, IHC | High cross-reactivity concerns |
| Anti-photosystem protein antibodies | Nanogram range | Highly conserved | WB, IHC | Often cross-react across species |
| Anti-transcription factor antibodies | Variable | Often specific | ChIP, EMSA | Often low abundance targets |
Methodological adaptations:
Plant-specific extraction methods are critical for all plant protein antibodies
Removal of interfering compounds (phenolics, pigments) is essential for clean results
Sample preparation protocols often need customization based on plant species and tissue type
Understanding these comparative aspects helps researchers select appropriate controls and validation strategies for PCR12 antibody applications .
Integrating antibody-based PCR12 detection with genetic approaches creates a powerful research strategy:
Complementary insights:
Genetic approaches (knockouts, RNAi, CRISPR) reveal phenotypic consequences of PCR12 absence
Antibody-based approaches show where and when PCR12 protein is expressed
Combining both approaches can reveal post-transcriptional regulation mechanisms
Applications in genetic studies:
Confirming knockout/knockdown efficiency at protein level
Examining ectopic expression in overexpression lines
Analyzing protein stability and turnover in different genetic backgrounds
Detecting unexpected compensation by related proteins in mutant lines
Experimental strategy integration:
| Genetic Approach | Complementary Antibody Application | Research Insight Gained |
|---|---|---|
| CRISPR knockout | Western blot confirmation | Verify complete protein loss |
| RNAi knockdown | Quantitative ELISA | Measure knockdown efficiency |
| Inducible expression | Time-course Western blot | Determine protein induction kinetics |
| Domain mutations | Co-IP with PCR12 antibody | Identify domains required for protein interactions |
| Promoter fusions | Comparison with IHC | Validate reporter gene accuracy |
Data interpretation advantages:
Distinguishing between transcriptional and post-transcriptional effects
Identifying cases where protein persists despite mRNA changes
Understanding protein localization changes in different genetic backgrounds
This integrated approach provides more complete understanding of PCR12 function than either approach alone .
Several emerging technologies offer potential to expand PCR12 antibody applications:
Advanced microscopy applications:
Super-resolution microscopy for precise subcellular localization
FRET (Förster Resonance Energy Transfer) to study protein-protein interactions in vivo
Live-cell imaging using fluorescently-tagged secondary antibodies in permeabilized cells
Multiplex detection systems:
Simultaneous detection of PCR12 and other proteins using differentially labeled secondary antibodies
Single-cell proteomics approaches to analyze PCR12 expression in individual plant cells
Imaging mass cytometry for spatial proteomics applications
Proximity labeling approaches:
Antibody-guided enzymatic tagging (APEX, BioID) for identifying spatial protein networks
Targeted proximity proteomics to identify proteins co-localizing with PCR12
High-throughput applications:
Antibody arrays for analyzing PCR12 across multiple samples simultaneously
Automated immunostaining platforms for standardized detection
Machine learning approaches for image analysis of PCR12 localization patterns
These emerging approaches may allow researchers to address more complex questions about PCR12 function in plant biology .
When faced with conflicting results using PCR12 antibody:
Technical factors to evaluate:
Antibody lot-to-lot variation: Different production batches may have different characteristics
Sample preparation differences: Extraction methods significantly impact protein detection
Detection system sensitivity: ECL substrates vary widely in sensitivity and dynamic range
Protocol variations: Small differences in blocking, washing, or incubation can affect outcomes
Experimental design considerations:
Controls: Verify all appropriate controls were included in both experiments
Quantification methods: Different image analysis approaches may yield different results
Statistical analysis: Ensure appropriate statistical tests were applied to determine significance
Biological versus technical replicates: Distinguish between experiment-to-experiment variation and true biological differences
Resolution strategies:
Independent verification using alternative methods (e.g., mass spectrometry)
Side-by-side comparison using standardized protocols
Validation with genetic approaches (knockout/knockdown)
Cross-laboratory validation with shared materials
Documentation and reporting recommendations:
Record detailed methodological information including antibody lot numbers
Include representative images of full blots including molecular weight markers
Report all validation experiments performed
Consider pre-registration of experimental protocols to reduce bias